Straits Times Index
3,363.68 -13.97 (-0.41%) S&P 500
4,176.08 +56.87 (+1.38%) Dow
33,974.75 -118.21 (-0.35%) Nasdaq
12,158.80 +342.48 (+2.90%) BTC-USD
23,834.03 +809.78 (+3.52%) CMC Crypto 200
544.53 -0.79 (-0.14%)
ABT May 2023 125.000 call
| Previous close | 0.9700 |
| Open | 0.8900 |
| Bid | 0.8600 |
| Ask | 0.9300 |
| Strike | 125.00 |
| Expiry date | 2023-05-19 |
| Day's range | 0.8900 - 0.8900 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.05k |
- Motley Fool
2 Top Dividend Growth Stocks to Buy in February
They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.
- Motley Fool
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
It's that time of year when Wall Street analysts start adjusting their predictions, and one dividend-paying stock, in particular, is getting a lot of positive attention. Abbott Laboratories (NYSE: ABT) reported fourth-quarter earnings on Thursday, Jan. 26. Since then, Sanford C. Bernstein, Raymond James, Stifel Nicolaus, and Barclays have all raised their price targets on the healthcare conglomerate.
- Zacks
Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
